Development of bespoke algorithms and analysis tools for the detection of small labelled targets in lung models of infection, using Ex Vivo Lung Perfusion datasets
A Contract Award Notice
by THE UNIVERSITY OF EDINBURGH
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £234K
- Sector
- PROFESSIONAL
- Published
- 05 Sep 2022
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
The University of Edinburgh, The Queen's Medical Research Institute, 57 Little France Crescent, Edinburgh, EH16 4TJ
1 buyer
- Edinburgh University Edinburgh
1 supplier
- Firefinch Sofware Edinburgh
Description
Development of bespoke algorithms and analysis tools for the detection of small labelled targets in lung models of infection, using Ex Vivo Lung Perfusion (EVLP) datasets. The service provider will also provide on-going maintenance and technical support for the software, and address any defects that are highlighted during the lifetime of the client's (Translational Healthcare Technologies Group) LungSpy clinical study.
Total Quantity or Scope
Continued development of bespoke algorithms and analysis tools for the detection of small labelled targets in lung models of infection, using Ex Vivo Lung Perfusion (EVLP) datasets. The service provider will also provide on-going maintenance and technical support for the software, and address any defects that are highlighted during the lifetime of the THT Group’s LungSpy clinical study.
Award Detail
| 1 | Firefinch Sofware (Edinburgh)
|
Award Criteria
| Clinical data management expertise, | 35 |
| Ability to develop bespoke algorithms and analysis tools for the detection of small labelled targets in lung models of infection. | 35 |
| price | 30 |
CPV Codes
- 73000000 - Research and development services and related consultancy services
- 73200000 - Research and development consultancy services
Legal Justification
These additional services to be delivered by the service provider enable the Translational Healthcare Technologies Group (THT) to build on existing acquisition analysis techniques that have taken years to develop. Were THT to switch suppliers, it would cause substantial rework and introduce unacceptable additional risks and costs to the current projects. Without the incumbent's continued input and expertise regarding data management, the LungSpy study will perforce be paused to further recruitment, (up to 80 participants with a variety of suspected lung conditions are being recruited from within the Royal Infirmary of Edinburgh), which would jeopardise the delivery of the study endpoints and the start of a GBP 2.5M Wellcome Trust funded multi-site ICU clinical study. In reality, new algorithms would be required and the team would lose years of effort.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** (SC Ref:705675)
Reference
- ocds-h6vhtk-0365b4
- FTS 024761-2022